Rural Health
Resources by Topic: Pharmacy and prescription drugs
Review of the 340B Drug Pricing Program
Provides extensive background information about the 340B Program, explains the Health Resources and Services Administration's (HRSA) oversight functions, and details requirements for the various covered entities, including rural hospitals and Federally Qualified Health Centers (FQHCs). Also makes recommendations for clarifying the 340B Program's scope and ensuring program integrity is maintained.
Date: 01/2018
Sponsoring organization: House Committee on Energy and Commerce
view details
Provides extensive background information about the 340B Program, explains the Health Resources and Services Administration's (HRSA) oversight functions, and details requirements for the various covered entities, including rural hospitals and Federally Qualified Health Centers (FQHCs). Also makes recommendations for clarifying the 340B Program's scope and ensuring program integrity is maintained.
Date: 01/2018
Sponsoring organization: House Committee on Energy and Commerce
view details
Quality Improvement and Care Coordination: Implementing the CDC Guideline for Prescribing Opioids for Chronic Pain
A guide to help primary care providers, practices, and healthcare systems manage patients who are on long-term opioid therapy. Provides an evidence-based prescribing guideline, quality improvement measures, and practice-level care coordination strategies. Appendix F provides examples of comprehensive management approaches, including discussion of telehealth approaches that could be used in rural communities.
Date: 2018
Sponsoring organization: Centers for Disease Control and Prevention
view details
A guide to help primary care providers, practices, and healthcare systems manage patients who are on long-term opioid therapy. Provides an evidence-based prescribing guideline, quality improvement measures, and practice-level care coordination strategies. Appendix F provides examples of comprehensive management approaches, including discussion of telehealth approaches that could be used in rural communities.
Date: 2018
Sponsoring organization: Centers for Disease Control and Prevention
view details
Behavioral, Mental, and Physical Health Characteristics and Opioid Medication Misuse among Community Pharmacy Patients: A Latent Class Analysis
Study of opioid misuse risk factors based on mental, behavioral, and physical health characteristics for patients in 2 rural and 2 urban Pennsylvania counties. Uses latent class analysis methodology to identify combinations of indicators that may be visible to pharmacists and that may suggest increased risk of opioid misuse, including age, employment, whether a pharmacy is in a rural area, and education level.
Author(s): Gerald Cochran, Valerie Hruschak, Jennifer L. Bacci, Kenneth C. Hohmeier, Ralph Tarter
Citation: Research in Social and Administrative Pharmacy, 13(6), 1055-1061
Date: 11/2017
view details
Study of opioid misuse risk factors based on mental, behavioral, and physical health characteristics for patients in 2 rural and 2 urban Pennsylvania counties. Uses latent class analysis methodology to identify combinations of indicators that may be visible to pharmacists and that may suggest increased risk of opioid misuse, including age, employment, whether a pharmacy is in a rural area, and education level.
Author(s): Gerald Cochran, Valerie Hruschak, Jennifer L. Bacci, Kenneth C. Hohmeier, Ralph Tarter
Citation: Research in Social and Administrative Pharmacy, 13(6), 1055-1061
Date: 11/2017
view details
Preventing Drug Abuse: Low Participation by Pharmacies and Other Entities as Voluntary Collectors of Unused Prescription Drugs
Report to Congress documenting low participation rates among pharmacies and other eligible entities in the Drug Enforcement Administration's (DEA) unused controlled substance collection and disposal program. Includes an outline of program requirements, a state-by-state overview of currently eligible and enrolled entities, and information about participation rates by rural and urban location.
Additional links: Full Report
Date: 10/2017
Sponsoring organization: Government Accountability Office
view details
Report to Congress documenting low participation rates among pharmacies and other eligible entities in the Drug Enforcement Administration's (DEA) unused controlled substance collection and disposal program. Includes an outline of program requirements, a state-by-state overview of currently eligible and enrolled entities, and information about participation rates by rural and urban location.
Additional links: Full Report
Date: 10/2017
Sponsoring organization: Government Accountability Office
view details
Antibiotic Prescription Fill Rates Declining in the U.S.
Examines antibiotic prescriptions filled as a result of an outpatient visit by commercially insured members of Blue Cross Blue Shield from 2010 to 2016. Includes statistics on antibiotic prescription fill rates in urban and rural counties by antibiotic type.
Date: 08/2017
Sponsoring organization: Blue Cross Blue Shield
view details
Examines antibiotic prescriptions filled as a result of an outpatient visit by commercially insured members of Blue Cross Blue Shield from 2010 to 2016. Includes statistics on antibiotic prescription fill rates in urban and rural counties by antibiotic type.
Date: 08/2017
Sponsoring organization: Blue Cross Blue Shield
view details
Drug Discount Program: Update on Agency Efforts to Improve 340B Program Oversight
Testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, U.S. House of Representatives, describing the Health Resources and Services Administration's (HRSA) actions and plans for improving 340B program oversight. Also provides an update on the Government Accountability Office's work regarding the 340B program and HRSA oversight. Includes information on 340B program participants, background, structure, audit frequency, and more.
Additional links: Examining HRSA's Oversight of the 340B Drug Pricing Program, Full Report
Date: 07/2017
Sponsoring organization: Government Accountability Office
view details
Testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, U.S. House of Representatives, describing the Health Resources and Services Administration's (HRSA) actions and plans for improving 340B program oversight. Also provides an update on the Government Accountability Office's work regarding the 340B program and HRSA oversight. Includes information on 340B program participants, background, structure, audit frequency, and more.
Additional links: Examining HRSA's Oversight of the 340B Drug Pricing Program, Full Report
Date: 07/2017
Sponsoring organization: Government Accountability Office
view details
Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder
Examines the barriers rural physicians who hold Drug Enforcement Agency (DEA) waivers to prescribe buprenorphine face. Seeks to explain why some rural physicians who hold a DEA waiver choose not to prescribe buprenorphine or treat a fewer number of patients than their waiver allows. Data was collected through a 2016 survey of all physicians with DEA waivers in rural areas.
Author(s): C. Holly A. Andrilla, Cynthia Coulthard, Eric H. Larson
Citation: Annals of Family Medicine, 15(4), 359-362
Date: 07/2017
view details
Examines the barriers rural physicians who hold Drug Enforcement Agency (DEA) waivers to prescribe buprenorphine face. Seeks to explain why some rural physicians who hold a DEA waiver choose not to prescribe buprenorphine or treat a fewer number of patients than their waiver allows. Data was collected through a 2016 survey of all physicians with DEA waivers in rural areas.
Author(s): C. Holly A. Andrilla, Cynthia Coulthard, Eric H. Larson
Citation: Annals of Family Medicine, 15(4), 359-362
Date: 07/2017
view details
Vital Signs: Changes in Opioid Prescribing in the United States, 2006-2015
Reports on opioid prescribing in the United States from 2006 to 2015. Includes data for metropolitan, micropolitan, and noncore (rural) counties. Also offers maps showing county-level prescriptions per capita in 2015 and changes in prescriptions per capita from 2010 to 2015.
Author(s): Gery P. Guy Jr., Kun Zhang, Michele K. Bohm, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 66(26), 697-704
Date: 07/2017
Sponsoring organization: Centers for Disease Control and Prevention
view details
Reports on opioid prescribing in the United States from 2006 to 2015. Includes data for metropolitan, micropolitan, and noncore (rural) counties. Also offers maps showing county-level prescriptions per capita in 2015 and changes in prescriptions per capita from 2010 to 2015.
Author(s): Gery P. Guy Jr., Kun Zhang, Michele K. Bohm, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 66(26), 697-704
Date: 07/2017
Sponsoring organization: Centers for Disease Control and Prevention
view details
Potentially Preventable Medication-Related Hospitalizations: A Clinical Pharmacist Approach to Assessment, Categorization, and Quality Improvement
Examines pharmacist-led quality improvement practices, implemented across rural and urban counties in Hawaii, to identify and categorize potentially preventable medication-related hospital admissions. Describes how data collected during the investigation is used to improve pharmacist interventions focused on reducing medication-related readmissions.
Author(s): Karen L. Pellegrin, Elizabeth Lee, Reece Uyeno, Chris Ayson, Roy Goo
Citation: Journal of the American Pharmacies Association, 57(6), 711-716
Date: 06/2017
view details
Examines pharmacist-led quality improvement practices, implemented across rural and urban counties in Hawaii, to identify and categorize potentially preventable medication-related hospital admissions. Describes how data collected during the investigation is used to improve pharmacist interventions focused on reducing medication-related readmissions.
Author(s): Karen L. Pellegrin, Elizabeth Lee, Reece Uyeno, Chris Ayson, Roy Goo
Citation: Journal of the American Pharmacies Association, 57(6), 711-716
Date: 06/2017
view details
A Project to Promote Adherence to Blood Pressure Medication Among People Who Use Community Pharmacies in Rural Montana, 2014–2016
Results of a project conducted by the Montana Department of Public Health and Human Services to evaluate interventions by community pharmacies to promote blood pressure medication adherence. Includes optional activity through which clinicians can earn continuing medical education credit.
Author(s): Carrie S. Oser, Crystelle C. Fogle, James A. Bennett
Citation: Preventing Chronic Disease, 14
Date: 06/2017
view details
Results of a project conducted by the Montana Department of Public Health and Human Services to evaluate interventions by community pharmacies to promote blood pressure medication adherence. Includes optional activity through which clinicians can earn continuing medical education credit.
Author(s): Carrie S. Oser, Crystelle C. Fogle, James A. Bennett
Citation: Preventing Chronic Disease, 14
Date: 06/2017
view details